Related Suggestion
(Dongguan, China, 5 March 2020) Fapon Biotech Inc. (Fapon) is premiering at booth 1F83, Medical Fair India from 5 to 7 March at the Bombay Convention and Exhibition Centre in Mumbai, India. Due to the traveling restriction caused by the COVID-19 virus, Fapon is one of the few Chinese exhibitors who attends the expo successfully.
Although it’s the first exhibition Fapon holds in India, but actually, the company has more than 10 years of cooperation experience with the diagnostic companies in India. Alongside the attention drawn to the global health emergency of COVID-19, which the infected cases in China are continuously declining while other countries are significantly increasing, a huge wave of visitors come to Fapon’s booth to learn about the company’s actions against the disease.
Driven by the corporate mission to Improve Human Health and Advance Human Development, Fapon provided PCR reagent solutions to over 80 industry partners in a few days after the COVID-19 virus hit China. A total of 2 million tests of high-quality PCR mixes were also donated to drive the COVID-19 screening and diagnosis.
“We are gratified to be involved in China’s COVID-19 battle with all the contributions being made”, spoke by Fapon International Sales Team, “In fact, we have millions of products had been used in CDC, Hospitals, ICLs via our partners’ networks. With the situation continue to escalate, we plan to donate these products internationally and hope to push the global virus diagnosis forward, we welcome industry partners to contact us if they need any help with the reagent development.”
Fapon’s premier underlines the PCR Reagent Solution that includes COVID-19 Real-Time RT-PCR Kit (PCR-Fluorogenic Probe) and Anstart One-Step RT-PCR Enzyme Mix (Lyophilized). Both products have earned favorable reputations from partners in China in dealing with the obstacles in COVID-19 assay development.
The COVID-10 Real-Time RT-PCR Kit (PCR-Fluorogenic Probe) can achieve simultaneously detection of ORF1ab and N genes. The contained enzyme mix is lyophilized to achieve a longer shelf-life after opening compared to liquid reagents. It is also compatible with Real-Time PCR instruments with FAM, HEX/VIC, and RED/ROX channels.
The Anstart One-Step RT-PCR Enzyme Mix (Lyophilized) is convenient for operation and transportation. The product is compatible with different primer probes, including COVID-19, flu, HFMD, etc. The real-time RT-PCR reaction can be completed in one tube to lower the contamination risk.
The show also highlights POCT and CLIA Solutions that provide practical diagnostic support to the Indian healthcare market as it is continuously diversifying and evolving. In 2020, Fapon POCT test panel is expected to expand to 36 parameters while the new 120T/H CLIA analyzer is also expected to launch.
Fapon’s actions on COVID-19 are extending outside China as infected cases surge globally. It will be a great honor to collaborate with global industry partners in this battle. By integrating the approach used and experience gained in China, Fapon strongly believes the company’s products and technologies in COVID-19 can help the healthcare industry save lives and winning the war together.
About Fapon
Fapon is a global leading IVD raw materials & one-stop solutions company founded in 2001. As one of the top IVD companies in Asia, Fapon serves some of the multi-nation leading diagnostic companies with 700+ partnerships worldwide.
Fapon offers an unmatched product combination of reagent raw materials and IVD one-stop solutions. It has 700+ reagent raw materials available for the application of Rapid Test, ELISA, CLIA, CMIA, Molecular Diagnostics, Biochemistry. Plus the solutions for POCT, CLIA, Immunoturbidimetry, DNA Library Preparation that provide reagent and analyzer services, Fapon can satisfy customers’ needs in different application scenarios.
